Guangzhou Wondfo Biotech Co.,Ltd

¥16.41As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300482Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.96%)
Div yield 1.34%
ROE (1.05%)
Medical Devices
Beta (5Y) 0.86
PE TTM —
TSR TTM (24.68%)
Mkt cap ¥7.623B
ROIC (1.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥21
29.38%
(81.69%)
Hold 10|6|6|7|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.22
0.22
0.23
0.23
13.69%
10.43%
16.28%
5.63%
Revenue¥M
376.0
396.9
418.3
423.1
6.73%
11.82%
12.04%
10.18%
Peers (US$1.143B)
Cap (US$)
PE
1.162B
17.03x
1.108B
—
Capital
TTM
5Y
10Y
Leveragex
0.305
0.305
0.216
EBIT/Intx
1.012
0.047
0.049
Own earn%
46.61
(261.79)
(254.36)
Sh yield%
41.10
19.10
19.43
Owners
Insiders/Inst%
1.71
31.80
Short interest%
1.93
SBC / revenue%
4.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
3–10
$1 testx
—
Incr. ROIC%
3